We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Promega Enters into Agreement with GeneCopoeia
News

Promega Enters into Agreement with GeneCopoeia

Promega Enters into Agreement with GeneCopoeia
News

Promega Enters into Agreement with GeneCopoeia

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Promega Enters into Agreement with GeneCopoeia"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Promega has entered into an agreement with GeneCopoeia to combine its HaloTag® protein fusion technology with GeneCopoeia’s extensive library of human and mouse open reading frame (ORF) OmicsLink™ sequences. The resulting OmicsLink ORF expression clones with HaloTag are ready for use, offering a potentially weeks of time savings to customers.

The large number of expression-ready ORF clones with HaloTag, combined with fluorescent or other ligands for HaloTag and optimized assay protocols, provide a complete solution broadly applicable to proteomics research, supporting both biochemical and cellular analysis of protein function.

“Our aim is to support scientists in their research, and this combined resource will enable them to easily incorporate these tools to improve protein function experiments,” explains Promega VP of Marketing Andy Bertera. “This collaboration with GeneCopoeia allows us to offer incredible breadth of prepared gene content to complement the multiple protein applications enabled by the HaloTag platform.”

“HaloTag complements our collections of genome-wide OmicsLink full length cDNA clones from human, mouse and other species," said Dr. Sun Lu, Executive Vice President of GeneCopoeia, Inc. GeneCopoeia’s 20,000 human and 15,000 mouse ORF clones were generated from sequence validated full length cDNA clones or high quality tissue cDNA libraries using the Company’s proprietary high-fidelity cloning technologies.

HaloTag is a multi-functional protein tag that binds covalently and specifically to a variety of synthetic ligands, and which enables tagged proteins to be labeled with fluorophores for both in vitro and in vivo imaging, or with immobilization agents (beads or other surfaces) for purification.  Covalent and specific binding of a variety of synthetic reporter and immobilization ligands to HaloTag fusion proteins allow detection and or solid-phase fixation of tagged proteins.

Advertisement